1. Home
  2. VCEL vs ATEC Comparison

VCEL vs ATEC Comparison

Compare VCEL & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$33.74

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Alphatec Holdings Inc.

ATEC

Alphatec Holdings Inc.

HOLD

Current Price

$10.78

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VCEL
ATEC
Founded
1989
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
VCEL
ATEC
Price
$33.74
$10.78
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
11
Target Price
$58.50
$22.00
AVG Volume (30 Days)
718.0K
2.2M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
15.04
EPS
0.32
N/A
Revenue
$276,259,000.00
$101,739,000.00
Revenue This Year
$19.10
$18.97
Revenue Next Year
$17.95
$16.26
P/E Ratio
$106.66
N/A
Revenue Growth
16.45
N/A
52 Week Low
$28.95
$8.82
52 Week High
$45.97
$23.29

Technical Indicators

Market Signals
Indicator
VCEL
ATEC
Relative Strength Index (RSI) 54.54 31.47
Support Level $30.41 $10.21
Resistance Level $34.34 $11.43
Average True Range (ATR) 1.76 0.55
MACD 0.29 -0.04
Stochastic Oscillator 83.11 8.91

Price Performance

Historical Comparison
VCEL
ATEC

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About ATEC Alphatec Holdings Inc.

Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.

Share on Social Networks: